Wellington Management Group
NVO

Wellington Management Group’s Novo Nordisk NVO Stock Holding History

Wellington Management Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-260,619
Closed -$18M – 2062
2025
Q2 		$18M Sell
260,619
-761,088
-74% -$51.8M ﹤0.01% 998
2025
Q1 		$70.9M Buy
1,021,707
+191,272
+23% +$15.8M 0.01% 592
2024
Q4 		$71.4M Buy
830,435
+477,557
+135% +$51.6M 0.01% 611
2024
Q3 		$42M Buy
+352,878
New +$47.1M 0.01% 747
2016
Q1 		– Sell
-54,118
Closed -$1.57M – 2193
2015
Q4 		$1.57M Sell
54,118
-340,882
-86% -$9.44M ﹤0.01% 1693
2015
Q3 		$10.7M Sell
395,000
-180,800
-31% -$5.12M ﹤0.01% 1150
2015
Q2 		$15.8M Hold
575,800
– – ﹤0.01% 1099
2015
Q1 		$15.4M Hold
575,800
– – ﹤0.01% 1121
2014
Q4 		$12.2M Hold
575,800
– – ﹤0.01% 1181
2014
Q3 		$13.7M Buy
+575,800
New +$13.3M ﹤0.01% 1139

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wellington Management Group's NVO Position: Q3 2025 in Review

Wellington Management Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 260,619 shares — an estimated $18M sold.

Wellington Management Group first reported a position in NVO in Q3 2014 and held it in 10 quarters. The position peaked at $71.4M in Q4 2024. 1,398 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Wellington Management Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Wellington Management Group sold 260,619 Novo Nordisk shares in Q3 2025, an estimated $18M.
  • Wellington Management Group first reported a position in Novo Nordisk in Q3 2014 and held it in 10 quarters.
  • Wellington Management Group's Novo Nordisk position peaked at $71.4M in Q4 2024.
  • 1,398 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Wellington Management Group's 13F filing for Q3 2025, filed 14 Nov 2025.